跳至主要内容
临床试验/NCT03792607
NCT03792607Unknown不适用

Perturbation of Interactome Through Micro-RNA And Methylome Analyses In Diabetes Endophenotypes: the PIRAMIDE Study Design

Giuditta Benincasa1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2019年2月14日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
35
试验地点
1
主要终点
DNA methylation status both of CD4+ and CD8+ cells

研究概览

简要总结

PIRAMIDE study design will test the hypothesis that simultaneous interactions between DNA methylation and microRNAs may hit T2D candidate genes and predict the development of T2D-related cardiovascular complications.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Clinical Diagnosis of Type 2 Diabetes. In according to current guidelines, diabetes is diagnosed by evidence of impairing fast glucose (IFG) > 7.0 mmol/L (>125 mg/dl), post prandial glycemia > 11.1 mmol/L (>200 mg/dl), and evidence of glycated hemoglobin (HbA1c) > 6.6%. Clinical and demographic characteristics of study population will be avaiable from datasets generated by physicians.
  • Clinical Diagnosis of macrovascular dysfunction.
  • Exclusion Criteria:
  • Patients with known history of cancer, malignancy disorders, active infections, and chronic or immune-mediated diseases.

结局指标

主要结局

DNA methylation status both of CD4+ and CD8+ cells

时间窗: 3 Months

Using Methylation 27K BeadChip platform based on Bisulfite conversion technology, DNA methylation profile of 35 preselected T2D patients will be measured both in CD4+ and CD8+ cells collected from peripheral blood respect with controls.

Bioinformatics analysis to predict putative novel T2D candidate genes

时间窗: 6 Months

The network-based algorithm "Weighted Human DNA methylation PPI network (WMPN)" will be applied to methylome data in order to obtain a disease module containing the crucial differentially methylated genes both in CD4+ and CD8+ cells from T2D patients and controls.

RNA sequencing analysis both in CD4+ and CD8+ cells

时间窗: 3 Months

RNA sequencing analysis by using Illumina HiSeq2000 Next Generatin Sequencing (NGS) platform will be performed for identifying differentially expressed micro-RNA and mRNA target both in CD4+ and CD8+ cells isolated from T2D patients and controls .

次要结局

  • ROC curves to evaluate putative DNA methylation/microRNA interactions as prognostic biomarkers of cardiovascular dysfunction in T2D patients(12 Months)

研究者

发起方
Giuditta Benincasa
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Giuditta Benincasa

Principal Investigator GIUDITTA BENINCASA

University of Campania "Luigi Vanvitelli"

研究点 (1)

Loading locations...

相似试验